Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives $100.30 Consensus PT from Analysts

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have received a consensus rating of “Moderate Buy” from the eleven research firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $100.30.

A number of analysts have weighed in on the company. BTIG Research upped their price target on Merit Medical Systems from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Citigroup reissued an “outperform” rating on shares of Merit Medical Systems in a report on Monday, April 20th. Barrington Research set a $114.00 target price on shares of Merit Medical Systems in a research note on Friday, July 31st. Piper Sandler upped their target price on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 target price on shares of Merit Medical Systems in a research report on Friday, July 31st.

Institutional Trading of Merit Medical Systems

Several hedge funds have recently modified their holdings of MMSI. Great Lakes Advisors LLC bought a new position in shares of Merit Medical Systems in the second quarter valued at approximately $322,000. Bank of New York Mellon Corp acquired a new position in shares of Merit Medical Systems in the 2nd quarter worth approximately $28,470,000. State of Wyoming bought a new stake in Merit Medical Systems during the 2nd quarter worth approximately $79,000. Gradient Investments LLC bought a new stake in Merit Medical Systems during the 2nd quarter worth approximately $1,657,000. Finally, GAMMA Investing LLC increased its holdings in Merit Medical Systems by 235.4% during the 2nd quarter. GAMMA Investing LLC now owns 3,250 shares of the medical instruments supplier’s stock valued at $225,000 after purchasing an additional 2,281 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Up 0.8%

NASDAQ MMSI opened at $89.75 on Friday. Merit Medical Systems has a 1-year low of $59.74 and a 1-year high of $94.75. The company has a market capitalization of $5.36 billion, a price-to-earnings ratio of 37.09, a PEG ratio of 2.24 and a beta of 0.48. The stock’s 50 day moving average is $72.76 and its two-hundred day moving average is $71.95. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The business had revenue of $418.84 million during the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.Merit Medical Systems’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities analysts forecast that Merit Medical Systems will post 3.81 earnings per share for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.